Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study

CompletedOBSERVATIONAL
Enrollment

595

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
HypertensionChronic Kidney Disease
Trial Locations (12)

15213

University of Pennsylvania, Pittsburgh

15260

University of Pittsburg, Pittsburgh

20052

George Washington University, Washington D.C.

27109

Wake Forest University, Winston-Salem

32224

Mayo Clinic Jacksonville, Jacksonville

44106

Case Western Reserve University, Cleveland

44195

Cleveland Clinic, Cleveland

55455

University of Minnesota, Minneapolis

80045

University of Colorado Denver, Denver

84103

University of Utah, Salt Lake City

94340

Stanford University, Palo Alto

98195

University of Washington, Seattle

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Utah

OTHER

NCT01475747 - Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study | Biotech Hunter | Biotech Hunter